NPI 1508856170: Open Payments
NPI 1508856170. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 5 payments from 3 companies in 2025. Trend: 2023 $3,936 · 2024 $1,746 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $246 |
| Alpha Cognition USA, Inc. | 1 | $112 |
| Alkermes, Inc. | 2 | $55 |
Products named: CAPLYTA, Zunveyl, ARISTADA, LYBALVI.
